EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial

Louise R A Olde Nordkamp iD, Jolien A de Veld iD, Abdul Ghani, Jürgen Kuschyk iD, Hendrik Bonnemeier iD, Kerstin Bode iD, Lucas V A Boersma iD, Anouk de Weger iD, Jonas S S G de Jong iD, Ward P J Jansen iD, Marco Alings iD, Nick Bijsterveld iD und 33 weitere

Circulation · 22.07.2025 · 152 (3) · 172-182

DOI: 10.1161/circulationaha.125.074576 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Circulation, erschienen am 22.07.2025. Verfasst von Louise R A Olde Nordkamp und 44 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University of Amsterdam, Amsterdam, the Netherlands (L.R.A.O.N., J.A.d.V., L.V.A.B., A.d.W., J.R.d.G., L.A.D., S.P., W.v.d.…. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Electric Countershock. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boston Scientific Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The PRAETORIAN trial (A Prospective, Randomized Comparison of Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy) investigated the efficacy and safety of the subcutaneous implantable cardioverter defibrillator (S-ICD) compared with a transvenous ICD (TV-ICD) and showed noninferiority of the S-ICD with regard to the composite end point of device-related complications and inappropriate shocks after 49.1 months. Complications associated with transvenous leads are expected to occur after longer follow-up. The PRAETORIAN-XL trial aims to investigate whether the S-ICD is superior to the TV-ICD with respect to device-related complications at 8-year follow-up. METHODS: The PRAETORIAN trial randomized patients with a class I or IIa indication for ICD therapy without the need for pacing to either S-ICD or TV-ICD among 39 centers in the United States and Europe between March 2011 and January 2017. The follow-up was extended after 49.1 months by an additional 4 years for the PRAETORIAN-XL trial. The primary end point was the composite of all device-related complications. Complications could be related or unrelated to the lead and minor or major, with major complications being those requiring an invasive intervention. End points were analyzed according to the modified intention-to-treat principle using a Fine-Gray subdistribution hazards model to account for competing risks. An as-treated analysis was performed using a Cox proportional hazards model with device type as time-dependent variable. RESULTS: Patients were randomized to S-ICD (n=426) and TV-ICD (n=423). Twenty-one percent of the S-ICD group versus 18% of the TV-ICD group were women. The median age at implantation was 63 (interquartile range, 54–69) years for the S-ICD and 64 (interquartile range, 56–69) years for the TV-ICD. After a median follow-up of 87.5 months, all device-related complications (major and minor combined) were not significantly different in the modified intention-to-treat analysis (subdistribution hazard ratio, 0.73 [95% CI, 0.48–1.12]); P =0.15). However, TV-ICD patients more often had a major complication or lead-related complication ( P =0.03 and P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Defibrillators, ImplantableElectric CountershockHumansFemaleMaleMiddle AgedFollow-Up StudiesAgedProspective StudiesTime FactorsTreatment Outcome

Stichwörter der Autor:innen

complicationsdefibrillators, implantableelectrophysiology

Autor:innen und Institutionen

  • Department of Cardiology, University of Amsterdam, Amsterdam, the Netherlands (L.R.A.O.N., J.A.d.V., L.V.A.B., A.d.W., J.R.d.G., L.A.D., S.P., W.v.d.S., K.M.K., A.B.E.Q., T.F.B., A.A.M.W., L.S., R.E.K.).
  • Department of Cardiology, Isala Heart Centre, Zwolle, the Netherlands (A.G.).
  • First Department of Medicine, University Medical Center Mannheim, Mannheim, Germany (J.K.).
  • German Center for Cardiovascular Research Partner Site Heidelberg, Mannheim, Germany (J.K.).
  • Christian Albrechts University Kiel, Kiel, Germany (H.B.).
  • Department of Electrophysiology, Heart Center at University of Leipzig, Leipzig, Germany (K.B.).

ORCID-Profile: Louise R A Olde Nordkamp, Jolien A de Veld, Jürgen Kuschyk, Hendrik Bonnemeier, Kerstin Bode, Lucas V A Boersma, Anouk de Weger, Jonas S S G de Jong, Ward P J Jansen, Marco Alings, Nick Bijsterveld, Mikhael F El-Chami, Rypko J Beukema, Kevin Vernooy, Berit T Philbert, Petr Neuzil, Peter Nordbeck, Jurren M van Opstal, Cornelis P Allaart, David J Wright, Michael Knaut, Timothy R Betts, Zachary I Whinnett, Pier D Lambiase, Joris R de Groot, Alexandru B Chicos, Stefan Kääb, Suneet Mittal, Alida E Borger van der Burg, Shari Pepplinkhuizen, Willeke van der Stuijt, Jose M Dizon, Elijah R Behr, Martin C Burke, Kirsten M Kooiman, Anne-Floor B E Quast, Tom F Brouwer, Arthur A M Wilde, Lonneke Smeding, Reinoud E Knops

Förderung

  • Boston Scientific Corporation

Zitieren

APA

Olde Nordkamp, L. R. A., de Veld, J. A., Ghani, A., Kuschyk, J., Bonnemeier, H., Bode, K., Boersma, L. V. A., de Weger, A., de Jong, J. S. S. G., Jansen, W. P. J., Alings, M., Bijsterveld, N., El-Chami, M. F., Beukema, R. J., Vernooy, K., Philbert, B. T., Neuzil, P., Nordbeck, P., van Opstal, J. M., …, & PRAETORIAN-XL Investigators (2025). Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial. Circulation, 152(3), 172-182. https://doi.org/10.1161/circulationaha.125.074576

Vancouver

Olde Nordkamp LRA, de Veld JA, Ghani A, Kuschyk J, Bonnemeier H, Bode K, et al. Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial. Circulation. 2025;152(3):172-182. doi:10.1161/circulationaha.125.074576

BibTeX
@article{OldeNordkamp2025,
  author = {Olde Nordkamp, Louise R A and de Veld, Jolien A and Ghani, Abdul and Kuschyk, Jürgen and Bonnemeier, Hendrik and Bode, Kerstin and Boersma, Lucas V A and de Weger, Anouk and de Jong, Jonas S S G and Jansen, Ward P J and Alings, Marco and Bijsterveld, Nick and El-Chami, Mikhael F and Beukema, Rypko J and Vernooy, Kevin and Philbert, Berit T and Neuzil, Petr and Nordbeck, Peter and van Opstal, Jurren M and Allaart, Cornelis P and Wright, David J and Knaut, Michael and Betts, Timothy R and Whinnett, Zachary I and Lambiase, Pier D and de Groot, Joris R and Chicos, Alexandru B and Nemirovksy, Dimitry and Kääb, Stefan and Mittal, Suneet and Borger van der Burg, Alida E and Dijkshoorn, Leonard A and Pepplinkhuizen, Shari and van der Stuijt, Willeke and Dizon, Jose M and Miller, Marc A and Behr, Elijah R and Burke, Martin C and Kooiman, Kirsten M and Quast, Anne-Floor B E and Brouwer, Tom F and Wilde, Arthur A M and Smeding, Lonneke and Knops, Reinoud E and PRAETORIAN-XL Investigators, PRAETORIAN-XL Investigators},
  title = {Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial},
  journal = {Circulation},
  year = {2025},
  volume = {152},
  number = {3},
  pages = {172--182},
  doi = {10.1161/circulationaha.125.074576}
}
Kostenlos starten →